サイト内検索

登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録

連絡先

TEL．03-5812-5270
FAX．03-3831-0495
E-mail：info@spi-information.com

関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。

Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

糖尿病ケアデバイス：新興国（中国、インド、ブラジル）の事業機会の評価、市場

レポート概要

本レポートは、中国とインドにおける糖尿病ケアデバイス市場における重要な市場データ、分析、さらには同市場における市場展望、市場勢力図、および市場動向に関する情報を提供します。また、同市場に影響を及ぼす重要な動向についての包括的情報、市場力学における重要な分析的内容も含み、さらに、市場勢力図、主要パイプライン製品や技術提供についても補足します。

■調査範囲

  • 主な市場セグメントは、血糖モニタリングとインスリンデリバリーです。
  • 2002〜2009年までの年間市場収益と2016年までの7年間の予測、および2009年の企業別シェアデータを提供します。
  • 糖尿病ケアデバイス市場内における重要な市場動向、市場促進および抑制因子を定性的に分析します。
  • 主要企業、市場勢力図、および主なパイプライン製品と技術についての情報を提供します。
  • 主要企業は、F. Hoffmann-La Roche Ltd.社、LifeScan, Inc.社、Bayer HealthCare AG社、Abbott Laboratories社、Medtronic, Inc.社、Becton, Dickinson and Company社、Novo Nordisk A/S.社です。
  • GlobalData社の業界専門家のチームによる独自のデータベース、一次的および二次的研究、および社内の分析から、データと情報を提供します。

レポート詳細

目次

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction and Overview
2.1 GlobalData Research Guidance

3 Disease Overview: Diabetes
3.1 Type I Diabetes
3.1.1 Introduction
3.1.2 Etiology, Disease Symptoms and Risk Factors
3.1.3 Pathophysiology
3.1.4 Epidemiology
3.1.5 Device Based Disease Treatment and Management: Insulin Delivery
3.2 Type 2 Diabetes
3.2.1 Introduction
3.2.2 Etiology, Disease Symptoms and Risk Factors
3.2.3 Pathophysiology
3.2.4 Epidemiology
3.2.5 Device Based Disease Treatment and Management:

4 Diabetes Care Devices, Emerging Markets: Market Characterization
4.1 Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 – 2009
4.2 Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
4.3 Diabetes Care Devices, Emerging Markets, Key Company Shares
4.4 Diabetes Care Devices, Emerging Markets, Key Market Trends
4.4.1 Increased Government Programs for Diabetes Care Awareness
4.4.2 Localization of Manufacturing of Diabetes Care Devices by Big Players
4.5 Diabetes Care Devices, Emerging Markets, Market Dynamics
4.5.1 Market Drivers
4.5.2 Market Restraints

5 Glucose Monitoring, Emerging Markets: Market Characterization
5.1 Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 – 2009
5.2 Glucose Monitoring Strips, Emerging Markets, Forecast Revenue ($m), 2009 – 2016
5.3 Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 – 2009
5.4 Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
5.5 Glucose Monitoring, Emerging Markets, Market Dynamics
5.5.1 Market Drivers
5.5.2 Market Restraints
5.6 Glucose Monitoring, Emerging Markets, Key Company Shares
5.6.1 Glucose Monitoring, China, Key Company Shares, 2009
5.6.2 Glucose Monitoring, India, Key Company Shares, 2009
5.6.3 Glucose Monitoring, Brazil, Key Company Shares 2009

6 Insulin Delivery, Emerging Markets: Market Characterization
6.1 Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 – 2009
6.2 Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
6.3 Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 – 2009
6.4 Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
6.5 Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 – 2009
6.6 Insulin Pumps, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
6.7 Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 – 2009
6.8 Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
6.9 Insulin Delivery, Emerging Markets, Market Dynamics
6.9.1 Market Drivers
6.9.2 Market Restraints
6.10 Insulin Delivery, Emerging Markets, Key Company Shares, 2009
6.10.1 Insulin Delivery, China, Key Company Shares, 2009
6.10.2 Insulin Delivery, India, Key Company Shares 2009
6.10.3 Insulin Delivery, Brazil, Key Company Shares 2009

7 Diabetes Care Devices, Emerging Markets: Key Market Participants
7.1 Glucose Monitoring Devices Market
7.2 Insulin Delivery Devices Market
7.3 Company Profiles
7.3.1 F. Hoffmann-La Roche Ltd
7.3.2 LifeScan (Johnson & Johnson)
7.3.3 Bayer Healthcare
7.3.4 Abbott Laboratories
7.3.5 Becton, Dickinson and Company
7.3.6 Medtronic
7.3.7 Novo Nordisk
7.3.8 Other Companies

8 Appendix
8.1 Acronyms
8.2 Sources
8.3 Database
8.4 Research Methodology
8.5 Secondary Research
8.6 Primary Research
8.7 Models
8.8 Forecasts
8.9 Expert Panels
8.10 GlobalData Consulting
8.11 Contact Us
8.12 Disclaimer

List of Figures
Figure 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010
Figure 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national)
Figure 3: Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Figure 4: Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Figure 5: Diabetes Care Devices, China, Key Company Shares, 2009
Figure 6: Diabetes Care Devices, India, Key Company Shares, 2009
Figure 7: Diabetes Care Devices, Brazil, Key Company Shares, 2009
Figure 8: Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Figure 9: Glucose Monitoring Strips, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Figure 10: Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Figure 11: Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Figure 12: Glucose Monitoring, China, Key Company Shares, 2009
Figure 13: Glucose Monitoring, India, Key Company Shares, 2009
Figure 14: Glucose Monitoring, Brazil, Key Company Shares, 2009
Figure 15: Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Figure 16: Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Figure 17: Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Figure 18: Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Figure 19: Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Figure 20: Insulin Pumps, Emerging Markets, Forecasts Revenues ($m), 2009 – 2016
Figure 21: Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Figure 22: Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Figure 23: Insulin Delivery, China, Key Company Shares, 2009
Figure 24: Insulin Delivery, India, Key Company Shares, 2009
Figure 25: Insulin Delivery, Brazil, Key Company Shares, 2009
Figure 26: GlobalData Methodology

List of Tables
Table 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010
Table 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national)
Table 3: Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Table 4: Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Table 5: Diabetes Care Devices, China, Key Company Revenue ($m), 2009
Table 6: Diabetes Care Devices, India, Key Company Revenue ($m), 2009
Table 7: Diabetes Care Devices, Brazil, Key Company Revenue ($m), 2009
Table 8: Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Table 9: Glucose Monitoring Strips, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Table 10: Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Table 11: Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Table 12: Glucose Monitoring, China, Key Company Revenue ($m), 2009
Table 13: Glucose Monitoring, India, Key Company Revenue ($m), 2009
Table 14: Glucose Monitoring, Brazil, Key Company Revenue ($m), 2009
Table 15: Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Table 16: Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Table 17: Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Table 18: Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Table 19: Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Table 20: Insulin Pumps, Emerging Markets, Forecasts Revenues ($m), 2009 – 2016
Table 21: Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 – 2009
Table 22: Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 – 2016
Table 23: Insulin Delivery, China, Key Company Revenue ($m), 2009
Table 24: Insulin Delivery, India, Key Company Revenue ($m), 2009
Table 25: Insulin Delivery, Brazil, Key Company Revenue ($m), 2009
Table 26: F Hoffman-La Roche, Key Marketed Products, Emerging Markets, 2010
Table 27: Johnson & Johnson, Key Marketed Products, Emerging Markets, 2010
Table 28: Bayer Healthcare, Key Marketed Products, Emerging Markets, 2010
Table 29: Abbott Laboratories, Key Marketed Products, Emerging Markets, 2010
Table 30: Becton Dickinson & Company, Key Marketed Products, Emerging Markets, 2010
Table 31: Medtronic, Key Marketed Products, Emerging Markets, 2010
Table 32: NovoNordisk, Key Marketed Products, Emerging Markets, 2010
Table 33: Local Diabetes Care Device Companies in China and India

発刊日

2010/07/07

体裁

PDF / 51ページ

販売価格

3,500USD

発行

GlobalData

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医療器具・機器

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる

PAGE